Support our Foundation of Myology project
ARGX-113-2003 – ADAPT NXT
A phase 3b, randomised, open-label, parallel-group study to evaluate different dosing regimens of intravenous efgartigimod in patients with generalised myasthenia gravis.
Support our Foundation of Myology project
A phase 3b, randomised, open-label, parallel-group study to evaluate different dosing regimens of intravenous efgartigimod in patients with generalised myasthenia gravis.